A study showed that the rates of gene mutation and upregulated expression of p53 in HCC patients were 31.5% and 35.0%, respectively, and the expression of p53 was significantly associated with the poor prognosis of HCC patients [21]. This evidence concerns the gene TP53 and hepatocellular carcinoma.